NIH-NINDS-21-002881- Notice of Intent

Submitted by patelsnv on
Post Date/ Solicitation Issue Date
Closing Response Date
Proposed Award Date
Project Title
Human GABAAR Stable Cell Line
Contracting Office
National Institute of Neurological Disorders and Stroke (NINDS)

Contact Points

Primary Contract Specialist

Briana
Oates
briana.oates@nih.gov
NAICS Code Number
541380
Laboratory Testing Services
Small Business Size Standard
137,298 employees
FPDS Classification Code
N/A
Estimated Period of Performance
Approximately 30 Days
Delivery of Goods
N/A
Set-Aside Status
Not Set Aside
Competition Status
Brand Name Only
Vendor Name
Charles River Laboratories
Address
GPO Box 27812
New York, NY 10087-7812
Single-Sole Source Determination
Pricing was obtained from other companies for stable cell lines for
this specific GABAAR subtype (i.e., α1β3γ2), ranging from $20,000 (e.g., SB Drug
Discovery) or higher. Charles River provided the cheapest option to obtain these cell
lines.

Upon request, up to two (2) replacement vials (total) of any cell line(s) purchased by
Customer will be provided to Customer at no charge, and any additional replacement
vials may be purchased for $500 per vial. Other companies have not provided us an
emergency option such as this.

The company has validated and provided information that the α1β3γ2 stable cell line
expresses well and works for electrophysiology experiments. In previous experiences,
transiently transfecting some GABAAR subunits leads to poor or no expression, this we
would like to purchase from a source that has already shown that they can express well.
Other companies have not been able to provide such data or are lacking the information.
A pdf of the data sheet titled “Human GABAA a1b3y2- HEK293” line will be attached.
Background/Description of Requirement

These human GABAAR stable cell line will greatly aid in the electrophysiological, cellular and molecular biology, and drug screening assays that will be taking place in the near future. We are currently doing transient transfection of each of the three subunits (α1, β3, γ2), but would like greater control and more reliable expression of these plasmids through stable expression. The stable cell line will help increase consistency and reliability for all these experiments.

Interested parties may identify in writing their interest and capability in response to this requirement. Responses to this notice shall contain sufficient information to establish the interested parties’ bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.

All responses must be received by closing date and must reference the announcement. Responses may be submitted electronically to the attention of the contract specialist. Fax responses will not be accepted.

All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency.